Design of a Chimeric Multi-Epitope Vaccine (CMEV) against Both <i>Leishmania martiniquensis</i> and <i>Leishmania orientalis</i> Parasites Using Immunoinformatic Approaches

Leishmaniasis is a parasitic disease caused by protozoan flagellates of the genus <i>Leishmania</i>. Recently, <i>Leishmania martiniquensis</i> and <i>Leishmania orientalis</i>, emerging species of <i>Leishmania</i>, were isolated from patients in Thai...

Full description

Bibliographic Details
Main Authors: Kentaro Imaizumi, Thararat Phurahong, Suradej Siripattanapipong, Kiattawee Choowongkomon, Saovanee Leelayoova, Mathirut Mungthin, Teerasak E-kobon, Sasimanas Unajak
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Biology
Subjects:
Online Access:https://www.mdpi.com/2079-7737/11/10/1460
_version_ 1827651456993329152
author Kentaro Imaizumi
Thararat Phurahong
Suradej Siripattanapipong
Kiattawee Choowongkomon
Saovanee Leelayoova
Mathirut Mungthin
Teerasak E-kobon
Sasimanas Unajak
author_facet Kentaro Imaizumi
Thararat Phurahong
Suradej Siripattanapipong
Kiattawee Choowongkomon
Saovanee Leelayoova
Mathirut Mungthin
Teerasak E-kobon
Sasimanas Unajak
author_sort Kentaro Imaizumi
collection DOAJ
description Leishmaniasis is a parasitic disease caused by protozoan flagellates of the genus <i>Leishmania</i>. Recently, <i>Leishmania martiniquensis</i> and <i>Leishmania orientalis</i>, emerging species of <i>Leishmania</i>, were isolated from patients in Thailand. Development of the vaccine is demanded; however, genetic differences between the two species make it difficult to design a vaccine that is effective for both species. In this study, we applied immuno-informatic approaches to design a chimeric multi-epitope vaccine (CMEV) against both <i>L. martiniquensis</i> and <i>L. orientalis</i>. We identified seven helper T lymphocyte (HTL) epitopes, sixteen cytotoxic T lymphocyte (CTL) epitopes, and eleven B-cell epitopes from sixteen conserved antigenic proteins found in both species. All these epitopes were joined together, and to further enhance immunogenicity, protein and peptides adjuvant were also added at the N-terminal of the molecule by using specific linkers. The candidate CMEV was subsequently analyzed from the perspectives of the antigenicity, allergenicity, and physiochemical properties. The interaction of the designed multi-epitope vaccine and immune receptor (TLR4) of the host were evaluated based on molecular dockings of the predicted 3D structures. Finally, in silico cloning was performed to construct the expression vaccine vector. Docking analysis showed that the vaccine/TLR4 complex took a stable form. Based on the predicted immunogenicity, physicochemical, and structural properties in silico, the vaccine candidate was expected to be appropriately expressed in bacterial expression systems and show the potential to induce a host immune response. This study proposes the experimental validation of the efficacy of the candidate vaccine construct against the two <i>Leishmania</i>.
first_indexed 2024-03-09T20:39:55Z
format Article
id doaj.art-78f2e5fffec1444b86e57658168ddc3e
institution Directory Open Access Journal
issn 2079-7737
language English
last_indexed 2024-03-09T20:39:55Z
publishDate 2022-10-01
publisher MDPI AG
record_format Article
series Biology
spelling doaj.art-78f2e5fffec1444b86e57658168ddc3e2023-11-23T22:59:55ZengMDPI AGBiology2079-77372022-10-011110146010.3390/biology11101460Design of a Chimeric Multi-Epitope Vaccine (CMEV) against Both <i>Leishmania martiniquensis</i> and <i>Leishmania orientalis</i> Parasites Using Immunoinformatic ApproachesKentaro Imaizumi0Thararat Phurahong1Suradej Siripattanapipong2Kiattawee Choowongkomon3Saovanee Leelayoova4Mathirut Mungthin5Teerasak E-kobon6Sasimanas Unajak7Department of Biochemistry, Faculty of Science, Kasetsart University, 50 Ngam Wong Wan, Chatuchak, Bangkok 10900, ThailandDepartment of Biochemistry, Faculty of Science, Kasetsart University, 50 Ngam Wong Wan, Chatuchak, Bangkok 10900, ThailandDepartment of Microbiology, Faculty of Science, Mahidol University, Bangkok 10400, ThailandDepartment of Biochemistry, Faculty of Science, Kasetsart University, 50 Ngam Wong Wan, Chatuchak, Bangkok 10900, ThailandDepartment of Parasitology, Phramongkutklao College of Medicine, Bangkok 10400, ThailandDepartment of Parasitology, Phramongkutklao College of Medicine, Bangkok 10400, ThailandDepartment of Genetics, Faculty of Science, Kasetsart University, 50 Ngam Wong Wan, Chatuchak, Bangkok 10900, ThailandDepartment of Biochemistry, Faculty of Science, Kasetsart University, 50 Ngam Wong Wan, Chatuchak, Bangkok 10900, ThailandLeishmaniasis is a parasitic disease caused by protozoan flagellates of the genus <i>Leishmania</i>. Recently, <i>Leishmania martiniquensis</i> and <i>Leishmania orientalis</i>, emerging species of <i>Leishmania</i>, were isolated from patients in Thailand. Development of the vaccine is demanded; however, genetic differences between the two species make it difficult to design a vaccine that is effective for both species. In this study, we applied immuno-informatic approaches to design a chimeric multi-epitope vaccine (CMEV) against both <i>L. martiniquensis</i> and <i>L. orientalis</i>. We identified seven helper T lymphocyte (HTL) epitopes, sixteen cytotoxic T lymphocyte (CTL) epitopes, and eleven B-cell epitopes from sixteen conserved antigenic proteins found in both species. All these epitopes were joined together, and to further enhance immunogenicity, protein and peptides adjuvant were also added at the N-terminal of the molecule by using specific linkers. The candidate CMEV was subsequently analyzed from the perspectives of the antigenicity, allergenicity, and physiochemical properties. The interaction of the designed multi-epitope vaccine and immune receptor (TLR4) of the host were evaluated based on molecular dockings of the predicted 3D structures. Finally, in silico cloning was performed to construct the expression vaccine vector. Docking analysis showed that the vaccine/TLR4 complex took a stable form. Based on the predicted immunogenicity, physicochemical, and structural properties in silico, the vaccine candidate was expected to be appropriately expressed in bacterial expression systems and show the potential to induce a host immune response. This study proposes the experimental validation of the efficacy of the candidate vaccine construct against the two <i>Leishmania</i>.https://www.mdpi.com/2079-7737/11/10/1460leishmaniasischimeric multi-epitope vaccineimmuno-informaticsin silico vaccine designreverse vaccinologyneglected tropical diseases
spellingShingle Kentaro Imaizumi
Thararat Phurahong
Suradej Siripattanapipong
Kiattawee Choowongkomon
Saovanee Leelayoova
Mathirut Mungthin
Teerasak E-kobon
Sasimanas Unajak
Design of a Chimeric Multi-Epitope Vaccine (CMEV) against Both <i>Leishmania martiniquensis</i> and <i>Leishmania orientalis</i> Parasites Using Immunoinformatic Approaches
Biology
leishmaniasis
chimeric multi-epitope vaccine
immuno-informatics
in silico vaccine design
reverse vaccinology
neglected tropical diseases
title Design of a Chimeric Multi-Epitope Vaccine (CMEV) against Both <i>Leishmania martiniquensis</i> and <i>Leishmania orientalis</i> Parasites Using Immunoinformatic Approaches
title_full Design of a Chimeric Multi-Epitope Vaccine (CMEV) against Both <i>Leishmania martiniquensis</i> and <i>Leishmania orientalis</i> Parasites Using Immunoinformatic Approaches
title_fullStr Design of a Chimeric Multi-Epitope Vaccine (CMEV) against Both <i>Leishmania martiniquensis</i> and <i>Leishmania orientalis</i> Parasites Using Immunoinformatic Approaches
title_full_unstemmed Design of a Chimeric Multi-Epitope Vaccine (CMEV) against Both <i>Leishmania martiniquensis</i> and <i>Leishmania orientalis</i> Parasites Using Immunoinformatic Approaches
title_short Design of a Chimeric Multi-Epitope Vaccine (CMEV) against Both <i>Leishmania martiniquensis</i> and <i>Leishmania orientalis</i> Parasites Using Immunoinformatic Approaches
title_sort design of a chimeric multi epitope vaccine cmev against both i leishmania martiniquensis i and i leishmania orientalis i parasites using immunoinformatic approaches
topic leishmaniasis
chimeric multi-epitope vaccine
immuno-informatics
in silico vaccine design
reverse vaccinology
neglected tropical diseases
url https://www.mdpi.com/2079-7737/11/10/1460
work_keys_str_mv AT kentaroimaizumi designofachimericmultiepitopevaccinecmevagainstbothileishmaniamartiniquensisiandileishmaniaorientalisiparasitesusingimmunoinformaticapproaches
AT thararatphurahong designofachimericmultiepitopevaccinecmevagainstbothileishmaniamartiniquensisiandileishmaniaorientalisiparasitesusingimmunoinformaticapproaches
AT suradejsiripattanapipong designofachimericmultiepitopevaccinecmevagainstbothileishmaniamartiniquensisiandileishmaniaorientalisiparasitesusingimmunoinformaticapproaches
AT kiattaweechoowongkomon designofachimericmultiepitopevaccinecmevagainstbothileishmaniamartiniquensisiandileishmaniaorientalisiparasitesusingimmunoinformaticapproaches
AT saovaneeleelayoova designofachimericmultiepitopevaccinecmevagainstbothileishmaniamartiniquensisiandileishmaniaorientalisiparasitesusingimmunoinformaticapproaches
AT mathirutmungthin designofachimericmultiepitopevaccinecmevagainstbothileishmaniamartiniquensisiandileishmaniaorientalisiparasitesusingimmunoinformaticapproaches
AT teerasakekobon designofachimericmultiepitopevaccinecmevagainstbothileishmaniamartiniquensisiandileishmaniaorientalisiparasitesusingimmunoinformaticapproaches
AT sasimanasunajak designofachimericmultiepitopevaccinecmevagainstbothileishmaniamartiniquensisiandileishmaniaorientalisiparasitesusingimmunoinformaticapproaches